Page last updated: 2024-10-26
thiorphan and Reperfusion Injury
thiorphan has been researched along with Reperfusion Injury in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hassan, M | 1 |
Kashimura, H | 1 |
Matsumaru, K | 1 |
Nakahara, A | 1 |
Fukutomi, H | 1 |
Muto, H | 1 |
Goto, K | 1 |
Tanaka, N | 1 |
Other Studies
1 other study available for thiorphan and Reperfusion Injury
Article | Year |
---|---|
Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats.
Topics: Animals; Aspartic Acid Endopeptidases; Endothelin-Converting Enzymes; Enzyme Inhibitors; Gastric Muc | 1997 |